Stanley Cheung

Stanley Cheung

Adelaide Medical School

Faculty of Health and Medical Sciences

Dr Stanley Cheung is a clinical haematologist with a particular interest in translational research in multiple myeloma. He is also the principal investigator on several clinical trials. he has a keen interest in medical teaching through tutorials with medical students and junior medical staff.

Dr Cheung is a medical graduate from the University of Hong Kong in 1996. He obtained his FHKCP in Haematology in 2005 following post-graduate training in Hong Kong and in Adelaide.

He moved to Adelaide in 2008, undertaking a PhD with the international expert in chronic myeloid leukemia, Professor Junia V Melo. Subsequently, Dr Cheung worked as a full time research fellow/postdoc fellow in Royal Adelaide Hospital and SAHMRI from 2013, joining the Adelaide Cancer Centre in February 2015.

  • Appointments
    Date Position Institution name
    2018 - ongoing Consultant and Director Adelaide Blood Specialists
    2015 - ongoing Consultant Haematologist Adelaide Cancer Centre
    2014 - ongoing Consultant Haematologist, Department of Haematology SA Pathology
    2013 - ongoing Clinical Lecturer, School of Medicine, Faculty of Health and Medical Sciences University of Adelaide
    2013 - 2015 Clinical Research Fellow, Department of Haematology Royal Adelaide Hospital
    2012 - 2013 Senior Haematology Registrar, Department of Haematology SA Pathology
    2011 - 2012 Transfusion Specialist Australian Red Cross Blood Transfusion Service (ARCBTS)
    2009 - 2012 Haematology Registrar, Department of Haematology SA Pathology
    2006 - 2008 Specialist Fellow (Junior Consultant), Department of Medicine Tuen Mun Hospital

  • Awards and Achievements
    Date Type Title Institution Name Country Amount
    2014 Scholarship Scholarship to support completion of Specialist Certificate in Clinical Research (Oncology) The Australasian Leukaemia & Lymphoma Group (ALLG) Australia -
    2008 Scholarship Funding for PhD study in the University of Adelaide Croucher Foundation Hong Kong -
    2005 Scholarship Scholarship to attend elective overseas training in Department of Haematology, Royal Adelaide Hospital Li Po Chun Charitable Trust Fund Committee Hong Kong -

  • Language Competencies
    Language Competency
    Chinese (Cantonese) Can read, write, speak, understand spoken and peer review
    Chinese (Mandarin) Can read, write, understand spoken and peer review

  • Education
    Date Institution name Country Title
    2014 - 2014 University of Melbourne Australia Specialist Certificate in Clinical Research (Oncology)
    2008 - 2014 University of Adelaide Australia PhD in Medicine
    1999 - 2000 Cardiff University United Kingdom Diploma of Palliative Medicine
    1991 - 1996 University of Hong Kong Hong Kong Bachelor of Medicine and Bachelor of Surgery (MBBS)

  • Postgraduate Training
    Date Title Institution Country
    2019 Associate Fellowship Royal Australasian College of Medical Administrators Australia
    2017 Fellowship Royal College of Physicians of Edinburgh (FRCP Edin) United Kingdom
    2013 Fellowship Royal Australasian College of Physicians (FRACP, Clinical Haematology) Australia
    2005 Fellowship Hong Kong College of Physicians (FHKCP, Haematology and Haematological Oncology) Hong Kong
    2004 Fellowship Hong Kong Academy of Medicine (FHKAM, Internal Medicine) Hong Kong
    2004 Fellowship Hong Kong College of Physicians (FHKCP, Internal Medicine) Hong Kong
    2001 Membership Hong Kong College of Physicians Hong Kong
    2000 Membership Royal College of Physicians United Kingdom

  • Journals
    Year Citation
    2021 Cheah, C., Jurczak, W., Lasica, M., Wickham, N. W., Wrobel, T., Walewski, J. A., . . . Tam, C. S. L. (2021). Updated results of the selective Bruton tyrosine kinase (BTK) inhibitor TG-1701, as monotherapy and in combination with ublituximab and umbralisib (U2) in patients (pts) with B-cell malignancies.. Journal of Clinical Oncology, 39(15_suppl), 7525.
    DOI
    2008 Cheung, K. C., Wong, L. G., & Yeung, Y. M. (2008). Treatment of CD33 positive refractory acute lymphoblastic leukemia with Mylotarg. Leukemia & Lymphoma, 49(3), 596-597.
    DOI WoS7 Europe PMC4
    2000 Cheung, K. C., & Tusi, H. S. (2000). An elderly man with acquired Haemophilia. The Hong Kong Practitioner, 22(3), 141-142.

  • Conference Items
    Year Citation
    2014 Cheung, K. C., Hewett, D., Yeung, D., Tan, C. W., To, L. B., & Zannettino, A. (2014). THE ROLE OF MERTK IN THE PROGRESSION OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) TO MYELOMA (MM). Poster session presented at the meeting of HAEMATOLOGICA. Milan, ITALY: FERRATA STORTI FOUNDATION.
Funding Body Project Year Value

Contributing Haematologists’ Committee Fund

A novel fusion transcript is a novel mediator of drug resistance in multiple myeloma

2016

$15,000.00

Contributing Haematologists’ Committee Fund
  1. The use of NGS to identify the genetic basis for Bortezomib resistance in patients exposed to Bort-containing induction regimens
  2. MRD monitoring of myeloma

2014

 $15,000.00

  • Memberships
    Date Role Membership Country
    2020 - ongoing Member Japanese Society of Hematology Japan
    2016 - ongoing Member Haematology Society of Australia and New Zealand Australia
    2014 - ongoing Member Haematology Society of Australia and New Zealand Australia
    2014 - ongoing Member Australian Leukaemia and Lymphoma Group (ALLG) Australia
    2008 - ongoing Member British Society of Haematology United Kingdom
    2003 - ongoing Member Hong Kong Society of Haematology Hong Kong
    2003 - ongoing Member American Hematology Society United States
    2000 - ongoing Member American Society of Haematology United States
Connect With Me